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This report summarizes the first year of activity on this study. The long-term goal of this project is to better understand why some prostate tumors grow aggressively while others are extremely slow growing lesions. The objective of the proposed research is to establish immortalized stromal cell lines derived from normal human prostate and from human prostate cancer and to use these cells to investigate the role of IGFs in prostate cancer growth. In this year we have focused on generating the molecular tools which are needed to progress with the proposed work. Retroviral vectors for the introduction and selection of all of our genes of interest (telomerase, Insulin-like growth factors and IGF binding protein 3) have been made and validated. Generation of immortalized stromal cell lines is underway and these cells are in the process of being characterized as they are generated. No major technical obstacles have cropped up. The project is close to its timeline predicted in the accepted statement of work.
14. 
Introduction
The long term goal of this project is to better understand why some prostate tumors grow aggressively while others are extremely slow growing lesions. The objective of the proposed research is to establish immortalized stromal cell lines derived from normal human prostate and from human prostate cancer and to use these cells to investigate the role of IGFs in prostate cancer growth. The central hypothesis on which this proposal is based is that prostate cancer progression is regulated, at least in part, by paracrine interactions between the prostatic stroma and the tumor. The first specific aim will generate immortalized cell lines with which to pursue mechanistic studies. The hypothesis is that fibroblastic cells immortalized by the insertion of a telomerase (hTERT) construct will behave in the same way in bioassays of their tumorpromoting activity as do the primary cell cultures from which they are derived. The rationale for these experiments is based upon observations by the PI and others on the role of stromal cells as promoters of carcinogenesis. The hypothesis of the second specific aim is that IGF family ligands act in a paracrine manner to elicit proliferation and/or tumorigenesis in human prostate cancer. The rationale for this specific aim is based on a variety of published observations connecting local and systemic levels of IGFs with prostatic growth and malignancy. The third specific aim will examine gene regulation in epithelial cells caused by changes in IGFs in the local microenvironment. The hypothesis is that changes in epithelial behavior are reflected in gene expression, the rationale is to identify gene products which might be targets for theraputic intervention. figure 1 ). The sequence of the construct has been checked. The ability of the retrovirus to infect human primary prostatic cell cultures has been confirmed. A variation of the proposed methodology was used in that a construct containing puromycin resistance was used in place of the selectible EGFP marker. (see fig 1) This modification makes cell selection more rapid and cost effective. Task lb. A series of normal and cancer associated prostatic stromal cell lines have been infected with the hTERT construct and puromycine selected. A real-time RT-PCR assay has been established to monitor and quantitate hTERT expression in the infected cell lines. As a check on protein expression a Western blot assay for hTERT expression is also being optimized.
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Task 1c. Screening for malignant transformation caused by the specific retroviral insertion point is ongoing. As noted in the original application this is more of a theoretical than a practical concern, however this is an aspect of retroviral immortalization which must be formally tested before further experiments can be performed. To this point no malignant transformation has been observed.
Task ld. Testing of the CAF/normal fibroblastic activity of the hTERT immortalized cells in a BPH-1 tissue recombination bioassay is also ongoing. This process is somewhat delayed as tissue recombinations cannot be performed with specific stromal cell strains until malignant transformation testing proves negative (task Ic). As more cells strains pass through this barrier the backlog is expected to ease. Task 2a. LZRS constructs for expression of IGF-1, IGF-2 and IGF-BP3 have been generated.
Construct maps shown in figure 2. The constructs are fully sequenced and validated. Conclusions.
This work is proceeding on the predicted timeline. No major hurdles have been encountered. The first year of this project, as described in the approved Statement of Work, was aimed at generating the molecular tools needed to proceed with the project. These tools are now in hand and the major experimental section of the project is now starting.
